Abstract
Objective
The aim of this study was to establish whether a spot urinary albumin/creatinine ratio (ACR) measured between 20 and 28 weeks of gestation can predict subsequent pre-eclampsia in asymptomatic pregnant women.
Design
Prospective observational study.
Subjects
The patients included sixty-two women with singleton pregnancy, normal renal function and no evident proteinuria, attending antenatal clinics between 20 and 28 weeks of gestation in a tertiary care hospital.
Methods
The ACR was determined from midstream urine sample taken between 20 and 28 weeks of gestation. Estimation of albumin was done by immunoturbidimetric microalbumin method and creatinine by modified Jaffe’s method.
Results
Incidence of pre-eclampsia in the study group was 12.90%. The cut-off value for ACR was taken as 35.5 mg/mol. The mean ACR in normotensive group was 19.26 ± 7.99, and in pre-eclampsia group it was 51.95 ± 18.78. For pre-eclampsia, screening in early pregnancy, spot ACR cut-off ≥35.5 mg/mol has sensitivity of 87.5%, specificity of 96.30%, PPV of 77.78% and NPV of 98.11%.
Conclusions
Spot urinary ACR values are higher in asymptomatic women in early pregnancy, who developed pre-eclampsia later on. When measured early in the second trimester, an ACR ≥ 35.5 mg/mmol predicted pre-eclampsia well before the onset of clinical manifestations with high sensitivity and specificity. It can be used as a good screening tool for predicting pre-eclampsia in early pregnancy.
Similar content being viewed by others
References
Kliman HJ. Uteroplacental blood flow the story of decidualization, menstruation and trophoblast invasion. Am J Pathol. 2011;157:1759–68.
Kozer E, Costei AM, Boskovic R, et al. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res Part B Dev Reprod Toxicol. 2013;68:70–84.
Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2012;116:402–14.
North RA, Ferrier C, Gamble G, et al. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol. 2015;35:357–62.
Mak A, Cheung MW, Cheak AA, et al. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology. 2011;49:281–8.
Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2012;5:173–92.
Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: the European prospective investigation into cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2014;33:189–98.
Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation. 2012;106:1777–82.
Baweja S, Kent A, Masterson R, et al. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin:creatinine ratio using high-performance liquid chromatography. BJOG. 2011;118:1126–32.
Risberg A, Larsson A, Olsson K, et al. Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and preeclampsia. Scand J Clin Lab Invest. 2014;64:17–24.
Fatema K, Khatun M, Akter S, et al. Role of urinary albumin in the prediction of preeclampsia. J Faridpur Med Coll. 2011;6(1):14–8.
Nisell H, Trygg M, Back R. Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension. Acta Obstet Gynecol. 2012;85:1327–30.
Shaarawy M, Salem ME. The clinical value of microtransferrinuria and microalbuminuria in the prediction of preeclampsia. Clin Chem Lab Med. 2011;39:29–34.
Sanchez-Ramos L, Gillen G, Zamora J, et al. The protein-to-creatinine ratio for the prediction of significant proteinuria in patients at risk for preeclampsia: a meta-analysis. Ann Clin Lab Sci. 2013;43(2):211–20.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Vineet Mishra, Preeti Goyal, Priyankur Roy, Sumesh Choudhary, Rohina Aggarwal, Khushali Gandhi, Bhumika Vyas and Shaheen Hokabaj declare that they have no conflicts of interest.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.
Additional information
Vineet V. Mishra, M.D., Ph.D., is Professor and HOD in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; Preeti A. Goyal, M.D., is Senior Resident in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; Roy Priyankur, M.S., is Clinical Fellow in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; S. Choudhary, M.D., DNB, is Assistant Professor in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; Rohina S. Aggarwal, M.D., is Professor in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; Khushali Gandhi, M.S., is Assistant Professor in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; Bhumika Vyas, DGO, is Senior Resident in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences; and Shaheen Hokabaj, DNB, is Clinical Fellow in Department of Obstetrics and Gynaecology, the Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences.
Rights and permissions
About this article
Cite this article
Mishra, V.V., Goyal, P.A., Priyankur, R. et al. Evaluation of Spot Urinary Albumin–Creatinine Ratio as Screening Tool in Prediction of Pre-eclampsia in Early Pregnancy. J Obstet Gynecol India 67, 405–408 (2017). https://doi.org/10.1007/s13224-016-0950-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-016-0950-7